Early detection of cancer plays a crucial role in improving patient outcomes and survival rates. Non-invasive and cost-effective methods for cancer screening are highly desirable. This comprehensive study focuses on the analysis of urine as a potential diagnostic tool for early detection of various cancers. Urine samples from a large cohort of individuals were collected and analyzed using advanced molecular and biochemical techniques. The study investigated specific cancer biomarkers present in urine that could indicate the presence of different types of cancers. The results demonstrated promising findings, showing significant associations between certain biomarkers in urine and specific cancer types. These findings highlight the potential of urine analysis as a non-invasive and accessible approach for early cancer detection, which could have significant implications for cancer screening and improving patient outcomes.

Urine analysis, cancer detection, early detection

Li P, Wang X, Xu X, et al. Urine-based biomarkers for the early detection of cancer: A review and update. Journal of Cancer. 2018;9(21):3742-3754.

Srinivasan S, Kaur J, Sodhi A, et al. Urine-based biomarkers for early cancer detection: A comprehensive review. International Journal of Molecular Sciences. 2019;20(8):E2011.

Azevedo AI, Cunha VM, Tavares Da Silva EJ, et al. Urine as a source of biomarkers for colorectal cancer diagnosis: A systematic review. Critical Reviews in Clinical Laboratory Sciences. 2020;57(3):194-209.

Zhou H, Jiang Y, Yin H, et al. Urine metabolomics for the early detection of bladder cancer: A systematic review and meta-analysis. Clinical and Translational Medicine. 2020;10(3):e101.

Abbasi R, Qiu X, Zhang Y, et al. Urine metabolomics for the early detection of hepatocellular carcinoma: A systematic review. Cancer Medicine. 2020;9(22):8596-8607.

Wang X, Wang C, Chen X, et al. Urinary proteomics for early diagnosis of bladder cancer: A systematic review and meta-analysis. Clinical Genitourinary Cancer. 2021;19(1):11-18.

Lee J, Taneja SS. The potential of urinary biomarkers for early bladder cancer detection: A systematic review and meta-analysis. World Journal of Urology. 2019;37(11):2393-2404.

Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: Opportunities and potential limitations. Molecular and Cellular Proteomics. 2004;3(4):367-378.

Shariat SF, Marberger MJ, Lotan Y, et al. Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer. Journal of Urology. 2006;176(3):919-926.

Lam S, MacAulay C, LeRiche JC, et al. A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. Journal of the National Cancer Institute. 2002;94(14):1001-1009.